Internal Medicine, Hematology & Oncology · Humacao, PR
NPI
1386639995
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Dufresne Street No.7
Humacao, PR, 00791
Phone (787) 852-5260
Medicare paid, 2024
$8,104
180 services
Medicare patients, 2024
17
Average age 78
Drug cost, 2024
$6.6M
1,628 prescriptions
Company payments, 2025
$4,166
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Graciany Miranda was code 99214 (office e&m - established), 63 times for 16 patients. In total Graciany Miranda billed 180 services in 6 codes, and Medicare paid $8,104.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 63 | 16 | $88.44 | $5,572 |
By year: 2022 $5,612 for 72 services; 2023 $5,118 for 60 services; 2024 $8,104 for 180 services.
Medicare prescription drug claims, 2024
In 2024, the drug Graciany Miranda prescribed most often to Medicare patients was Lupron Depot (Leuprolide Acetate), with 296 prescriptions and refills. In total Graciany Miranda wrote 1,628 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lupron Depot Leuprolide Acetate | 296 | 342 | 47 | $691K |
| Hydroxyurea Generic | 133 | 133 | 19 | $4,151 |
| Xtandi Enzalutamide | 122 | 122 | 13 | $1.7M |
| Retacrit Epoetin Alfa-Epbx | 118 | 118 | 63 | $123K |
| Anastrozole Generic | 104 | 132 | 18 | $1,613 |
| Letrozole Generic | 56 | 59 | Under 11 | $590 |
| Sprycel Dasatinib | 52 | 52 | Under 11 | $626K |
| Erleada Apalutamide | 44 | 44 | Under 11 | $654K |
| Rosuvastatin Calcium Generic | 40 | 76 | 15 | $401 |
| Kisqali Ribociclib Succinate | 28 | 28 | Under 11 | $492K |
| Methylprednisolone Generic | 27 | 27 | Under 11 | $166 |
| Synthroid Levothyroxine Sodium | 26 | 26 | Under 11 | $1,322 |
| Eligard Leuprolide Acetate | 26 | 41 | Under 11 | $19K |
| Calquence Acalabrutinib Maleate | 25 | 25 | Under 11 | $382K |
| Prolia Denosumab | 22 | 132 | 13 | $39K |
Brand drugs: 916 claims; generic drugs: 712 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Graciany Miranda $4,166 ($4,166 in general payments such as food, travel and fees) from 36 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $586.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 23 | $586 |
| E.R. Squibb & Sons, L.L.C. BMY | 22 | $477 |
| Pbg Puerto Rico LLC | 18 | $424 |
| Janssen Pharmaceuticals, Inc JNJ | 22 | $345 |
| Abbvie Inc. ABBV | 17 | $312 |
| Merck Sharp & Dohme LLC MRK | 11 | $230 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $226 |
| Genentech USA, Inc. ROG.SW | 8 | $184 |
| Incyte Corporation INCY | 6 | $178 |
| Bayer Puerto Rico Inc. BAYN.DE | 6 | $151 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.